Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

STOUGHTON - Kent G. Genter passed away unexpectedly on the morning of Sunday, June 8, 2025 after a long battle with familial amyloidosis. In the Fall of 2018, he became the second person to ever ...

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the 13 Biotech Stocks with Huge Upside Potential. It declared on June 9 ...

As multiple companies vie to expand on Alnylam’s success in commercializing RNAi therapeutics, the pioneering company has set ...

rb3.so-net.ne.jp Objective To elucidate the long-term effects of liver transplantation (LT) on familial amyloid polyneuropathy (FAP). Methods We investigated clinicopathological and biochemical ...

Shares of Intellia Therapeutics (NASDAQ: NASDAQ:NTLA) plunged 19% following a safety update from its ongoing Phase 3 MAGNITUDE study. The clinical trial, which is evaluating the company’s gene-editing ...

Detailed price information for Immix Biopharma Inc (IMMX-Q) from The Globe and Mail including charting and trades.

hATTR amyloidosis genetic testing If tests find ... anakinra and tocilizumab as possible treatments for hATTR. Consider a liver transplant. Since TTR is made in the liver, a liver transplant ...

The current standard first-line treatment for hereditary ATTR amyloidosis is liver transplantation, which allows suppression of the main source of variant TTR. However, large numbers of patients are ...